Skip to main content

Advertisement

Log in

Antibodies and myelination: facts and misacts

  • MULTIPLE SCLEROSIS AND RARE PATHOLOGIES
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract.

Polyreactive (auto)antibodies are frequently found in healthy subjects and are bona fide considered to be nonpathogenic. However, autoreactive B cells and circulating (auto)antibodies have been associated with several neurological syndromes, including demyelinating disorders. Whether these antibodies can have a real impact on disease development is still a matter of debate. Here, we briefly summarize some of the most recently published data on both the deleterious and the protective effects of antibodies in autoimmune demyelinating disorders of the central nervous system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pluchino, S., Zanotti, L. & Martino, G. Antibodies and myelination: facts and misacts. Neurol Sci 24 (Suppl 4), s231–s233 (2003). https://doi.org/10.1007/s10072-003-0084-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-003-0084-4

Key words

Navigation